{"id":"1dbf8bb4-de9b-40cc-9ba2-be6093ee0e73","arxiv_id":"2411.10983","paper_version":1,"verdict":"REJECT","confidence":"MODERATE","novelty_score":4.0,"correctness_risk":"high","formal_verification":"none","parameter_count":0,"one_line_summary":"A proposal for expert-guided multimodal AI that couples large language models with mechanistic patient simulators to generate safe, explainable, ethical insulin dosing plans.","lead":"This paper proposes a framework for combining clinician knowledge with AI models to personalize medical treatment, using insulin management for type 1 diabetes as an example. The authors describe how a large language model could generate treatment plans that are checked for safety by a patient-specific virtual model, but they do not test the framework.","discovery_kind":"extension","skeptic_critique":{"model":"deepseek-v4-flash","headline":"The central safety claim depends on a digital twin that the paper itself admits may be unidentifiable from normal-use data; no fidelity evidence is provided.","rationale":"The reader's weakest assumption identifies the digital twin's fidelity as the central risk, and I agree that this is the most load-bearing point. I strengthen the concern by pointing to the paper's own Section 2.2 admission that normal-use data may not identify all parameters of the BMM/LTC-NN digital twin. This is not an external objection but an internal limitation that the manuscript itself flags, and it directly undermines the use of the digital twin as a forward safety simulator for LLM-generated plans. The paper contains no empirical validation, no identifiability analysis, and no held-out test of the simulator's accuracy under exercise or pregnancy; the case study is a list of planned tasks (A1-A13), not a study with results. The proposed concrete test would settle whether the concern lands: if the parameters are identifiable and the simulator reproduces held-out exercise data, then the framework's key mechanism is at least plausible and the paper could be repositioned as a proposal needing implementation. If not, the ethical and safety claims in Section 2 cannot be supported. The reader's REJECT verdict remains appropriate because the manuscript asserts a hypothesis and calls it an evaluation without providing the evaluation; my concern does not change that verdict, so I recommend UNCHANGED.","tokens_in":10546,"tokens_out":4126,"duration_ms":45312,"concrete_test":"On a single T1D patient's normal-use CGM and insulin pump data (e.g., from the T1DEXI dataset, reference [30]), fit the LTC-NN/BMM digital twin as described in tasks A4 and A7, then compute bootstrap or profile-likelihood confidence intervals for the model parameters such as insulin sensitivity and glucose effectiveness. Then simulate a held-out exercise day and compare predicted CGM to observed CGM. If any parameter confidence interval is unbounded or multi-modal, or if the predicted CGM misses observed hypoglycemic or hyperglycemic events by more than 15 mg/dL median absolute error, the forward safety simulator cannot certify LLM-generated plans and the central hypothesis in Section 2 is unsupported.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The load-bearing condition for the central claim in Section 2 is that expert-knowledge-guided MAI can be trusted for generalizable, explainable, and ethical automation. In the T1D case study, this trust is carried entirely by the 'high-fidelity forward safety simulator' (tasks A7 and A8, Section 2.1.1). The paper never demonstrates that fidelity. The only direct statement about it is the limitation in Section 2.2: 'Data from normal usage of the system may be insufficient for identifiability of all the parameters.' That admission, together with the absence of any identifiability analysis or held-out validation (the paper cites only its own prior work, references [26] and [31]), leaves open that the BMM/LTC-NN digital twin can reproduce training data yet diverge under the rare exercise, pregnancy, or aging conditions it was not fitted to. Since the proposed ethical safety guarantee is exactly the forward simulation of LLM-generated plans (Figure 2), an unidentifiable or unfaithful digital twin would let unsafe plans pass the safety filter, directly contradicting the claimed ethical automation. The calibration stage does not repair this because task A11 is described as future work and no test results are reported.","agreement_with_reader":"partial"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper proposes a framework for developing and evaluating expert-guided multi-modal AI (MAI) for precision medicine, structured around three lifecycle stages: conceptualization, development, and calibration. The main hypothesis is that integration of clinician expert knowledge with data-driven AI enables generalized, transparent, explainable, and ethical automation. The framework is illustrated with a case study on Type 1 diabetes (T1D) insulin management, in which an embodied LLM generates insulin-delivery usage plans and a patient-specific digital twin (Bergman Minimal Model fitted by a liquid time constant neural network) acts as a forward safety simulator. The paper claims to evaluate this hypothesis, but the T1D case study is presented as a list of future tasks (A1--A13) with no experimental data, simulation results, or formal proofs. The only theoretical content is a recapitulation of existing multimodal learning theory (reference [23]).","tokens_in":10737,"tokens_out":3083,"duration_ms":32255,"significance":"If validated, the framework would provide a concrete route toward safe, personalized AI for medical decisions, particularly for T1D management during exercise and pregnancy. The paper's strengths are its explicit mapping of bioethics principles (beneficence, non-maleficence, autonomy, justice) to concrete development tasks, its co-design philosophy with clinician oversight, and the sensible use of publicly available datasets (JAEB, T1DEXI, NIH). It also clearly identifies a specific safety mechanism, the digital-twin-based forward simulator, as the arbiter of LLM-generated plans. However, the central hypothesis is asserted, not tested: the manuscript reports no evaluation of any component of the framework. The safety guarantee rests on a digital twin whose fidelity is asserted by reference to prior self-cited work and whose identifiability is admitted to be questionable. As it stands, the paper is a position/vision paper, and its stated claim of evaluation is unsupported.","major_comments":[{"comment":"The paper states (Section 2.1, final paragraph) \"In this paper, we evaluate this fundamental hypothesis...\" but no evaluation is presented. There are no experiments, no simulations, no quantitative results, and no formal proofs. The T1D case study (Section 2.1.1) is a catalog of planned tasks (A1--A13) with no results for any task. The claim of evaluation is therefore not supported by the manuscript content.","section":"Abstract and Section 2.1"},{"comment":"The safety of LLM-generated plans depends entirely on the forward safety simulator being a high-fidelity digital twin. The manuscript provides no evidence for this fidelity: no identifiability analysis, no held-out validation, and no comparison against clinical data for exercise, pregnancy, or aging scenarios. The only direct statement on this point is in Section 2.2: \"Data from normal usage of the system may be insufficient for identifiability of all the parameters.\" This admission, combined with the absence of validation, leaves open the possibility that unsafe plans pass the safety filter, directly undermining the claimed ethical automation. The calibration task A11, which would test digital twin accuracy, is described only as future work.","section":"Section 2.1.1, tasks A7 and A8, and Figure 2"},{"comment":"The theoretical justification for MAI (from reference [23]) is presented as the basis for the framework, and it is claimed that expert knowledge resolves the drawback of unknown structure of the connecting functions g_ij. This claim is plausible but entirely unverified in the paper. No experiment or simulation demonstrates that expert-selected learning functions actually reduce sample complexity or improve generalization in the T1D domain, so the core theoretical benefit remains an unsupported assertion.","section":"Section 2, MAI theory recapitulation"},{"comment":"The proposed digital twin learning and LLM integration are described as extensions of the authors' prior work (references [26], [27], [31]), which are cited as evidence of capability without including any of that prior work's validation data or metrics. Reference [31] is cited for \"high-fidelity fast simulation,\" but no fidelity measures are reported in this manuscript. Thus, the key capability on which the safety mechanism rests is not demonstrated within this paper and is not independently verifiable from the provided references.","section":"Section 2.1.1, Task A4 and references [26], [27], [31]"}],"minor_comments":[{"comment":"The phrase \"illustrate this framework with case study\" should read \"with a case study.\"","section":"Abstract"},{"comment":"There is a typo: \"Artificial Intelligene\" should be \"Artificial Intelligence.\"","section":"Introduction, first paragraph"},{"comment":"The caption begins \"Figure 2: . LLM planner...\" with an unnecessary space before the period; it should be cleaned up.","section":"Figure 2 caption"},{"comment":"The paper refers to \"Phi 2 [25]\" but reference [25] is the Gemini technical report. The reference numbering appears mismatched; please correct the citation.","section":"Section 2.1.1, Task A4"},{"comment":"There are typos: \"digiti twin\" should be \"digital twin\" and \"digitl\" should be \"digital.\"","section":"Section 2.2, Ethical statement"},{"comment":"Several references (e.g., [27]) lack complete venue and publication details, making them difficult to locate and verify.","section":"Reference list"}],"recommendation":"reject","confidential_remarks":"This manuscript is more of a workshop position paper than a complete research contribution. The central claim—that the framework is evaluated—is contradicted by the absence of any evaluation. The heavy reliance on the authors' own prior work, without including that work's evidence, further reduces the standalone value of this paper. The reference mismatch for [25] and the incomplete reference details suggest the manuscript is not yet publication-ready. If the authors intend to make a framework proposal, the title and claims should be revised to reflect that scope; as written, the paper does not meet the bar for a research journal. I would recommend reject, though the authors may consider resubmission as a vision paper after substantial revision."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Short version: this is a position paper, not a results paper. It lays out a three-stage framework for building ethically guided multi-modal AI for precision medicine and illustrates it with a T1D insulin-management case study. The framework is sensible and the digital-twin-as-safety-filter idea for LLM-generated treatment plans is timely and worth discussing. But the paper never tests its central hypothesis, the case study is a to-do list, and the one safety mechanism that carries the ethical claims is a digital twin whose fidelity is asserted rather than demonstrated.\n\nWhat is actually new: the explicit packaging of expert knowledge into conceptualization, development, and calibration stages, with bioethics woven into each. That organization is useful for practitioners. The authors also deserve credit for being honest in the ethical statement: they acknowledge that data from normal system use may be insufficient for identifying all digital twin parameters. That admission is directly at odds with the later talk of a 'high-fidelity forward safety simulator' and is never resolved.\n\nSoft spots: there are no experimental results, no simulations, no formal derivations. The LLM responses shown are stock GPT-3.5 output, not evidence about the framework. The key capability—recovering a faithful digital twin from sparse patient data—rests on the authors' own prior work (LTC-NN, CPS-LLM), cited but not independently verified. The paper says 'we evaluate this fundamental hypothesis' but gives no evaluation. The case study tasks A1-A13 are mostly plans, not completed work. The stress-test note is on target: if the digital twin is unidentifiable, the forward safety simulator can miss unsafe plans, and the ethical guarantee collapses. The paper does not address this beyond a one-line caveat.\n\nWho this is for: a workshop audience interested in a framework for ethical AI co-design, not readers looking for validated methodology.\n\nRecommendation: I would not send this to a full peer review as a technical contribution. If it is intended as a position paper, it should say so and drop the evaluation language. If the authors want it taken seriously, they need at least one concrete validation: fit the digital twin to real AID data and show it replicates held-out CGM traces under exercise or pregnancy conditions, then run the LLM-plus-safety-filter pipeline in simulation.","headline":"Position paper with a useful framework but no validation; the safety-critical digital twin is admitted to be potentially unidentifiable.","tokens_in":11276,"tokens_out":3858,"would_cite":false,"duration_ms":37688,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":false},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"This paper claims that clinician expert knowledge, integrated with multimodal AI and patient-specific digital twins, can make precision medicine AI generalizable, explainable, and ethical.","keywords":["precision medicine","multimodal AI","expert knowledge integration","digital twin","LLM safety evaluation","Type 1 diabetes","bioethics","co-design"],"falsifier":"Run a prospective study in which the digital twin simulates a proposed exercise or pregnancy plan forward and the patient then follows that plan under clinician supervision; if the twin's predicted glucose trace diverges from the measured CGM trace in ways that misclassify hypoglycemia risk or time in range, the safety-evaluation link is falsified.","tokens_in":10326,"feed_emoji":"🩺","tokens_out":7359,"duration_ms":70794,"temperature":0.7,"pith_summary":"This paper claims that AI for precision medicine can become generalizable, explainable, and ethically trustworthy if clinician expert knowledge is woven into every stage of the AI lifecycle, not added at the end. The authors evaluate this in Type 1 diabetes, where a language model generates personalized insulin-delivery plans for exercise and pregnancy that are checked by a patient-specific digital twin before a clinician approves them. The framework also names other precision medicine targets, including epilepsy seizure-onset localization and coronary artery disease prediction, where the same co-design loop would apply. If the central hypothesis holds, the result is a route to AI systems that propose, simulators that filter, and clinicians who decide, with safety and fairness built into the pipeline.","feed_headline":"Clinician-guided AI framework claims safer personalized insulin plans","feed_subtitle":"Digital twins simulate LLM plans before a clinician approves them for exercise and pregnancy.","key_machinery":"The central machinery is the two-step expert-guided integration loop. First, digital twin learning uses expert-identified learning functions $l_{ij}$, whose structure mirrors the true cross-modality relations $g_{ij}$, to fit multi-modal patient data and recover a clinically meaningful parameter set $\\Theta$; second, expert-guided deep learning uses $l_{ij}$ and $\\Theta$ as inputs to learn the overall response function $f(x_1,\\dots,x_n,\\Theta)$. In the Type 1 diabetes case study, the digital twin is a Bergman Minimal Model fitted to CGM and insulin data through a liquid time constant neural network, and the deep model is an embodied LLM that converts user queries into AID usage plans. The safety check is a forward simulation: each proposed plan is run through the twin, and the resulting robustness of a signal temporal logic specification quantifies plan quality, which is fed back to the LLM through RLHF or back-prompting until the plan is safe for clinician approval. This loop is what the framework claims will tie generalization, explainability, and bioethics to concrete clinical parameters.","core_discovery":"The central claim, stated in Section 2, is that integration of expert knowledge acquired by clinicians in the field with data-driven AI can enable generalized, transparent, explainable, and ethical automation. The paper evaluates this hypothesis in the context of personalized automated insulin delivery for Type 1 diabetes, where an LLM generates usage plans for exercise and pregnancy and a patient-specific digital twin acts as a forward safety simulator to judge them. The paper argues that because expert knowledge identifies the right modalities and the right structural learning functions, the learned model inherits both generalization, via multimodal-learning theory, and explainability, because outputs map back to clinically relevant parameters. The intended result is a co-designed human-machine collaboration in which clinicians make the final decision, and the framework is offered as an initial template for other precision medicine challenges.","pith_inferences":["Inference: the framework's practical value rests on the digital twin's fidelity under rare conditions, so the decisive test is a direct comparison of twin-simulated glucose traces against real CGM recordings during exercise and pregnancy.","Inference: the modular design suggests a transfer test, replace the endocrine model with a cardiac or neural mechanistic model and rerun the same LLM-plus-simulator loop to see if the claimed generalization benefits carry over.","Inference: because the paper acknowledges expert knowledge can be vague or conflicting, a natural addition is a formal consistency check on expert rules before they are encoded into the LLM or the twin.","Inference: the ecological-footprint task implies a measurable efficiency claim, a distilled exercise-only model should match the full model's plan-safety performance on embedded hardware, and that parity can be tested directly."],"forward_implications":["Personalized AID usage plans for exercise and pregnancy could be generated and tested in silico before a patient follows them, reducing reliance on population-level guidelines.","LLM-generated plans that are unsafe would be penalized by the digital-twin safety score before the plan reaches the clinician, providing a concrete safety gate for language-model outputs.","Because the clinician gives final approval, the framework preserves human accountability and patient autonomy while using AI for exploration and risk assessment.","The same three-stage co-design loop could be adapted to epilepsy seizure-onset detection and CAD prediction, with fairness checks such as age- or sex-stratified calibration built into the process.","Explanations would be expressed in clinically meaningful terms such as projected time in range, hypoglycemic events, and patient-specific model parameters rather than abstract attention weights."],"supporting_citations":[{"why":"It supplies the three-stage AI lifecycle, conceptualization, development, and calibration, that organizes the framework.","marker":"[13]"},{"why":"It is the prior demonstration that expert knowledge combined with AI outperforms AI alone in medical imaging, grounding the expert-guided MAI approach.","marker":"[2]"},{"why":"It gives the heterogeneity and connection conditions that justify the claimed generalization advantage of multimodal learning over unimodal learning.","marker":"[23]"},{"why":"It provides the liquid time constant neural network method used to recover digital twin parameters from implicit dynamics for patient-specific simulators.","marker":"[26]"},{"why":"It is the prior integration of LLAMA 2 with the LTC-NN digital twin for evaluating a single insulin bolus, extended here to full usage plans.","marker":"[27]"},{"why":"It establishes the digital twin as a high-fidelity fast forward simulator for safety evaluation in human-in-the-loop systems.","marker":"[31]"},{"why":"It identifies the base LLM, chosen because it has a fine-tunable API and is computationally efficient enough for the embodied LLM role.","marker":"[24]"},{"why":"It supplies real-world structured exercise data used to fit and calibrate the digital twin for exercise-related glycemic variability.","marker":"[30]"},{"why":"It supports the claim that LLMs can identify complex ethical issues even if they cannot resolve all real-world ethical dilemmas.","marker":"[28]"}],"fun_headline_variants":["AI and clinicians team up for safer insulin plans","Expert-guided AI framework for ethical T1D care","Digital twin simulates AI insulin plans before clinician OK","Co-designed framework for transparent AI in precision medicine","LLM plans checked by digital twin, clinician decides"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The load-bearing premise is that a patient-specific digital twin recovered from sparse CGM and insulin data can faithfully simulate glycemic response during rare conditions such as exercise and pregnancy, accurately enough to judge whether a language-model-generated insulin plan is safe.","fun_headline_variants_meta":{"raw":{"variants":["AI and clinicians team up for safer insulin plans","Expert-guided AI framework for ethical T1D care","Digital twin simulates AI insulin plans before clinician OK","Co-designed framework for transparent AI in precision medicine","LLM plans checked by digital twin, clinician decides"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000209,"raw_usage":{"total_tokens":1363,"prompt_tokens":855,"completion_tokens":508,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":471,"completion_tokens_details":{"reasoning_tokens":434}},"tokens_in":471,"tokens_out":508,"duration_ms":6010,"temperature":1.0,"reasoning_tokens":434,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-12T19:04:07.432237+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Run a prospective study in which the digital twin simulates a proposed exercise or pregnancy plan forward and the patient then follows that plan under clinician supervision; if the twin's predicted glucose trace diverges from the measured CGM trace in ways that misclassify hypoglycemia risk or time in range, the safety-evaluation link is falsified.","supporting_citations":[{"cited_title":"Chiang, R","cited_arxiv_id":null,"evidence_quote":"It supplies the three-stage AI lifecycle, conceptualization, development, and calibration, that organizes the framework."},{"cited_title":"Kamboj, A","cited_arxiv_id":null,"evidence_quote":"It is the prior demonstration that expert knowledge combined with AI outperforms AI alone in medical imaging, grounding the expert-guided MAI approach."},{"cited_title":"Lu, A theory of multimodal learning, volume 36, 2023, pp","cited_arxiv_id":null,"evidence_quote":"It gives the heterogeneity and connection conditions that justify the claimed generalization advantage of multimodal learning over unimodal learning."},{"cited_title":"Machine Learning Meets Differential Equations: From Theory to Applications","cited_arxiv_id":null,"evidence_quote":"It provides the liquid time constant neural network method used to recover digital twin parameters from implicit dynamics for patient-specific simulators."},{"cited_title":"Banerjee, A","cited_arxiv_id":null,"evidence_quote":"It is the prior integration of LLAMA 2 with the LTC-NN digital twin for evaluating a single insulin bolus, extended here to full usage plans."},{"cited_title":"Banerjee, P","cited_arxiv_id":null,"evidence_quote":"It establishes the digital twin as a high-fidelity fast forward simulator for safety evaluation in human-in-the-loop systems."},{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"It supplies real-world structured exercise data used to fit and calibrate the digital twin for exercise-related glycemic variability."},{"cited_title":"Ferrario, N","cited_arxiv_id":null,"evidence_quote":"It supports the claim that LLMs can identify complex ethical issues even if they cannot resolve all real-world ethical dilemmas."}],"review_version":1}